Literature DB >> 17516247

Purification and characterization of an immunomodulatory Peptide from bovine placenta water-soluble extract.

Xin-Ping Fang1, Wen-Shui Xia, Qing-Hai Sheng, Yu-Liang Wang.   

Abstract

An immunomodulatory peptide was isolated from bovine placenta water-soluble extract and purified by consecutive chromatography on DEAE Sepharose CL-6B, Sephadex G-25, and Sephasil C18 column using lymphocyte proliferation assay to identify the active fractions. The immunomodulatory peptide showed a dose-dependent stimulating effect on lymphocyte proliferation. The isoelectric point of the immunodulatory peptide was determined to be 3.82 by capillary isoelectric focusing electrophoresis. The molecular mass of the immunomodulatory peptide was determined to be 2133.52 Da by mass spectrometry. The first 10 amino acid sequence of the immunomodulatory peptide was Tyr-X-Phe-Leu-Gly-Leu-Pro-Gly-X-Thr. This immunomodulatory peptide showed no significant homology with other immunomodulatory peptides. Additionally, it was thermostable, retaining about 60% of immune activity after incubating at 80 degrees C for 30 min.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516247     DOI: 10.1080/10826060701386653

Source DB:  PubMed          Journal:  Prep Biochem Biotechnol        ISSN: 1082-6068            Impact factor:   2.162


  3 in total

1.  Porcine placenta hydrolysates enhance osteoblast differentiation through their antioxidant activity and effects on ER stress.

Authors:  Hwa-Young Lee; Han-Jung Chae; Sun-Young Park; Jong-Hyun Kim
Journal:  BMC Complement Altern Med       Date:  2016-08-17       Impact factor: 3.659

2.  Preparation and Characterization of Antioxidant Peptides from Fermented Goat Placenta.

Authors:  Yinchen Hou; Jiejing Zhou; Wangwang Liu; Yongxia Cheng; Li Wu; Gongming Yang
Journal:  Korean J Food Sci Anim Resour       Date:  2014-12-31       Impact factor: 2.622

3.  Porcine placenta hydrolysates regulate calcium disturbance in MC3T3-E1 osteoblastic cells.

Authors:  Hwa-Young Lee; Hyung-Ryong Kim; Sun-Young Park; Han-Jung Chae; Jong-Hyun Kim
Journal:  BMC Complement Altern Med       Date:  2016-07-25       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.